1. Home
  2. DK vs NKTR Comparison

DK vs NKTR Comparison

Compare DK & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

HOLD

Current Price

$48.11

Market Cap

2.5B

Sector

Energy

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$57.16

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DK
NKTR
Founded
2001
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
DK
NKTR
Price
$48.11
$57.16
Analyst Decision
Hold
Strong Buy
Analyst Count
17
7
Target Price
$39.94
$146.67
AVG Volume (30 Days)
999.4K
891.7K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
2.19%
N/A
EPS Growth
95.67
N/A
EPS
N/A
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
$6.85
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
86.00
52 Week Low
$18.94
$7.99
52 Week High
$49.50
$109.00

Technical Indicators

Market Signals
Indicator
DK
NKTR
Relative Strength Index (RSI) 62.59 21.72
Support Level $42.06 $52.99
Resistance Level $48.91 $61.98
Average True Range (ATR) 2.37 2.84
MACD 0.35 -0.96
Stochastic Oscillator 87.78 0.88

Price Performance

Historical Comparison
DK
NKTR

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has three segments: Refining segment and Logistics segment and retail segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Share on Social Networks: